{"id":"https://openalex.org/W67811585","doi":"https://doi.org/10.1007/978-1-4615-3446-4_8","title":"Leukotrienes and Asthma","display_name":"Leukotrienes and Asthma","publication_year":1992,"publication_date":"1992-01-01","ids":{"openalex":"https://openalex.org/W67811585","doi":"https://doi.org/10.1007/978-1-4615-3446-4_8","mag":"67811585"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-4615-3446-4_8","doi":"https://doi.org/10.1007/978-1-4615-3446-4_8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4615-3446-4_8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asthma Treatment","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4247679304","display_name":"Asthma Treatment"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028764377","display_name":"Joshua Rokach","orcid":"https://orcid.org/0000-0003-1814-7505","observed_orcids":["https://orcid.org/0000-0003-1814-7505"]},"institutions":[{"id":"https://openalex.org/I106959904","display_name":"Florida Institute of Technology","ror":"https://ror.org/04atsbb87","country_code":"US","type":"education","lineage":["https://openalex.org/I106959904"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Rokach","raw_affiliation_strings":["Claude Pepper Institute for Aging and Therapeutic Research, Florida Institute of Technology, Melbourne, Florida, 32901, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Claude Pepper Institute for Aging and Therapeutic Research, Florida Institute of Technology, Melbourne, Florida, 32901, USA","institution_ids":["https://openalex.org/I106959904"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Barth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I106959904","display_name":"Florida Institute of Technology","ror":"https://ror.org/04atsbb87","country_code":"US","type":"education","lineage":["https://openalex.org/I106959904"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Barth","raw_affiliation_strings":["Claude Pepper Institute for Aging and Therapeutic Research, Florida Institute of Technology, Melbourne, Florida, 32901, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Claude Pepper Institute for Aging and Therapeutic Research, Florida Institute of Technology, Melbourne, Florida, 32901, USA","institution_ids":["https://openalex.org/I106959904"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114259185","display_name":"T. J. Bach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Bach","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002428014","display_name":"Michel L. Belley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M. Belley","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E. Champion","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"E. Champion","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"C. Chan","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034986851","display_name":"L. Charette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"L. Charette","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031797767","display_name":"Stella E. Charleson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. Charleson","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003924295","display_name":"Robert N. DeHaven","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. N. DeHaven","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Denis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. Denis","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060164161","display_name":"Richard A. F. Dixon","orcid":"https://orcid.org/0000-0002-8138-7256","observed_orcids":["https://orcid.org/0000-0002-8138-7256"]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R. Dixon","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075553198","display_name":"George J. Eiermann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Eiermann","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072740937","display_name":"Diane Ethier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. Ethier","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041666909","display_name":"Jilly F. Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J. Evans","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112017151","display_name":"A. W. Ford\u2010Hutchinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A. W. Ford-Hutchinson","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034127446","display_name":"R\u00e9jean Fortin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R. Fortin","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111843356","display_name":"Aidan Foster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A. Foster","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006596384","display_name":"Richard Frenette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R. Frenette","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109283957","display_name":"J. Y. GAUTHIER","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J. Y. Gauthier","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031615776","display_name":"John W. Gillard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J. Gillard","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008509634","display_name":"Yves Girard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Y. Girard","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080032386","display_name":"Y. Guidon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Y. Guidon","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028172062","display_name":"Pierre Hamel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P. Hamel","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077720552","display_name":"S. Hopple","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Hopple","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001964581","display_name":"John L. Humes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Humes","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019538932","display_name":"L. Hupe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Hupe","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027754866","display_name":"Thomas R. Jones","orcid":"https://orcid.org/0000-0001-5824-5324","observed_orcids":["https://orcid.org/0000-0001-5824-5324"]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"T. R. Jones","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108724394","display_name":"Serge L\u00e9ger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. Leger","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066088177","display_name":"Claire Leveill\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"C. Leveill\u00e9","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022604032","display_name":"A. Lord","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A. Lord","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073997383","display_name":"Silvi Luell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Luell","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052434985","display_name":"Paul Masson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P. Masson","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108440382","display_name":"C. S. McFarlane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"C. S. McFarlane","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111897450","display_name":"D. E. Mc McIntyre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. E. Mc McIntyre","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035642806","display_name":"Joseph M. Metzger","orcid":"https://orcid.org/0000-0002-3882-4326","observed_orcids":["https://orcid.org/0000-0002-3882-4326"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Metzger","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051304657","display_name":"Roger D. Meurer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Meurer","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Miller","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017577722","display_name":"Howard E. Morton","orcid":"https://orcid.org/0000-0003-4084-2977","observed_orcids":["https://orcid.org/0000-0003-4084-2977"]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"H. E. Morton","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017628106","display_name":"Evan E. Opas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Opas","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110182953","display_name":"Stephen G Pacholok","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Pacholok","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055492725","display_name":"L. Peterson","orcid":"https://orcid.org/0000-0001-7061-4153","observed_orcids":["https://orcid.org/0000-0001-7061-4153"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Peterson","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049658499","display_name":"Hanna Piechuta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"H. Piechuta","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049593363","display_name":"Sheng\u2010Shung Pong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. S. Pong","raw_affiliation_strings":["Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Inflammation, Merck Sharp & Dohme Research Laboratories Rahway, New Jersey, 07065, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063518304","display_name":"Denis Riendeau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. Riendeau","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000326101","display_name":"Carol A. Rouzer","orcid":"https://orcid.org/0000-0001-6827-1534","observed_orcids":["https://orcid.org/0000-0001-6827-1534"]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"C. Rouzer","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107846295","display_name":"H R Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"H. Williams","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063566841","display_name":"Robert Norman Young","orcid":"https://orcid.org/0000-0002-8235-6080","observed_orcids":["https://orcid.org/0000-0002-8235-6080"]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R. Young","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007739276","display_name":"Christiane Yoakim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"C. Yoakim","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005486528","display_name":"Robert J. Zamboni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R. Zamboni","raw_affiliation_strings":["Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, P. O. box 1005, Pointe Claire-Dorval Qu\u00e9., Canada, H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2821,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.82809612,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"93","last_page":"103"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leukotrienes","display_name":"leukotrienes","score":0.996999979019165},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.6610000133514404},{"id":"https://openalex.org/keywords/slow-reacting-substance-of-anaphylaxis","display_name":"slow reacting substance of anaphylaxis","score":0.9259999990463257},{"id":"https://openalex.org/keywords/leukotriene-c4","display_name":"leukotriene C4","score":0.8320000171661377},{"id":"https://openalex.org/keywords/leukotriene-d4","display_name":"leukotriene D4","score":0.9909999966621399},{"id":"https://openalex.org/keywords/leukotriene-e4","display_name":"leukotriene E4","score":1.0},{"id":"https://openalex.org/keywords/arachidonic-acid-metabolites","display_name":"arachidonic acid metabolites","score":0.9850000143051147},{"id":"https://openalex.org/keywords/bronchoconstriction","display_name":"bronchoconstriction","score":0.9980000257492065},{"id":"https://openalex.org/keywords/allergic-airway-inflammation","display_name":"allergic airway inflammation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/antigen-challenge","display_name":"antigen challenge","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6181622743606567},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.5446758270263672},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4449712634086609},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4441797733306885},{"id":"https://openalex.org/C2780769369","wikidata":"https://www.wikidata.org/wiki/Q4375","display_name":"Bronchoconstriction","level":3,"score":0.41536378860473633},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38373783230781555},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3521754741668701},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2069893777370453},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15701425075531006},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-1-4615-3446-4_8","doi":"https://doi.org/10.1007/978-1-4615-3446-4_8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4615-3446-4_8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asthma Treatment","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W270348947","https://openalex.org/W1509307264","https://openalex.org/W1520264805","https://openalex.org/W1605053531","https://openalex.org/W1824477642","https://openalex.org/W1922797677","https://openalex.org/W1968792529","https://openalex.org/W1970448142","https://openalex.org/W1981211197","https://openalex.org/W1982778295","https://openalex.org/W1988831361","https://openalex.org/W1993920430","https://openalex.org/W1995712293","https://openalex.org/W1996400030","https://openalex.org/W2004305634","https://openalex.org/W2004351423","https://openalex.org/W2038575244","https://openalex.org/W2046262741","https://openalex.org/W2046679315","https://openalex.org/W2049796670","https://openalex.org/W2052828945","https://openalex.org/W2053939881","https://openalex.org/W2054842438","https://openalex.org/W2066950125","https://openalex.org/W2072259664","https://openalex.org/W2072870749","https://openalex.org/W2078720424","https://openalex.org/W2079125531","https://openalex.org/W2095265570","https://openalex.org/W2119979570","https://openalex.org/W2131074536","https://openalex.org/W2140290771","https://openalex.org/W2168049797","https://openalex.org/W2201511800","https://openalex.org/W2327878210","https://openalex.org/W2405081674","https://openalex.org/W2405389313","https://openalex.org/W2413045881","https://openalex.org/W2460099356","https://openalex.org/W2889107333"],"related_works":["https://openalex.org/W2133253302","https://openalex.org/W2419061764","https://openalex.org/W2068811641","https://openalex.org/W2485852244","https://openalex.org/W95558536","https://openalex.org/W431391007","https://openalex.org/W938024907","https://openalex.org/W2410133807","https://openalex.org/W4247805008","https://openalex.org/W2049796670"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}